Lung disease causes nearly 11% of deaths in India. And yet awareness and access to treatment remain poor. Myths and unequal ...
Silent lung diseases develop without symptoms and many people are unaware of the changes to their lungs. Its early symptoms ...
Dr. Singhi speaks with us about the importance of biomarker testing and what you need to know to get the best lung cancer ...
Non-small cell lung cancer has been notoriously difficult to treat because of its aggressive nature and tendency to relapse, even after initial successful treatments. This resistance is often linked ...
Doctors are experimenting with using lower doses of blockbuster cancer drugs. It could help hundreds of thousands of lives — if pharmaceutical companies would allow it.
“Our findings suggest that cancer survivors may be at increased risk of metastatic relapse after common respiratory viral ...
A pilot study sought to measure the impact of Program CONNECT on the confidence, knowledge, and skills of health professional trainees to navigate patients through lung cancer screening.
Thirty-nine Quincy residents will participate in the 2025 Jimmy Fund Walk presented by Hyundai on Oct. 5. The annual event aims to raise $9.5 million to support adult and pediatric cancer care and ...
THIO-101 Phase 2 trial to enroll patients in the U.S. as part of the expansion of the study in third-line treatment for advanced non-small cell lung cancer (NSCLC) ...
The thoughtful integration of artificial intelligence (AI) with multiomics is reshaping the diagnostic and therapeutic landscape in localized non–small cell lung cancer (NSCLC). Although the hype ...
THIO-101 Phase 2 trial to enroll patients in the U.S. as part of the expansion of the study in third-line treatment for advanced non-small cell lung cancer (NSCLC) CHICAGO, Sept. 24, 2025 (GLOBE NEWSW ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results